It can detect 811 genes at the same time, covering 26 common solid tumors.
This medical testing can dynamicly and real-timely monitor the development and the therapeutic effect of cancers.
Guidance on targeted drug use for breast cancer
Genetic testing and medication guidance multiple genes related to targeted breast cancer drugs were simultaneously tested at one time
Guidance on targeted drug use for colorectal cancer
Genetic testing and medication guidance multiple genes related to targeted colorectal cancer drugs were simultaneously tested at one time
Guidance on targeted drug use for lung cancer
Provide drug guidance for 26 lung cancer targeted drugs at the same time
Standard edition guidance for targeted drug use in cancer
Automatic bioinformatics analysis software and database are used to interpret the drug-gene correlation and assist doctors to develop personalized targeted drug regimen
Assist the clinician to make treatment plan and prognosis prediction
B-RAF/K-RAS/EGFR gene mutation detection
It is used to screen the dominant population of tumor targeted drugs and provide reference for clinicians
Cover all solid tumors and assist doctors to make personalized medication plan